Literature DB >> 11303304

Anti-nuclear envelope antibodies: Clinical associations.

G Nesher1, R Margalit, Y J Ashkenazi.   

Abstract

OBJECTIVES: Characterization of the clinical associations and clinical implications of antibodies reacting with antigens of the nuclear envelope.
METHODS: Description of an illustrative case and a MEDLINE search-assisted literature review of relevant cases.
RESULTS: With indirect immunofluorescence, autoantibodies directed against various antigens of the nuclear envelope stain the nucleus in a ring-like (rim) pattern. Autoantibodies against 5 antigenic components of the nuclear envelope have been described: anti-gp210, p62, lamina, lamina-associated polypeptides, and lamin B receptor. Antibodies to antigens of the nuclear pore complex, such as gp210 and p62, are highly specific (> 95%) for primary biliary cirrhosis and may aid in the serologic diagnosis of this condition, especially in cases in which antimitochondrial antibodies are not detectable. In contrast, antilamin antibodies are not disease-specific but seem to be associated with lupus anticoagulant or anticardiolipin antibodies, antiphospholipid syndrome, thrombocytopenia, autoimmune liver diseases, and arthralgia. High-titered antilamin antibodies help to define a subset of lupus patients with antiphospholipid antibodies who are at a lower risk of developing thrombotic events. In addition, preliminary data suggest that the presence of antilamin antibodies may be helpful in the diagnosis of chronic fatigue syndrome.
CONCLUSIONS: Each of the antibodies reacting with nuclear membrane antigens has its own spectrum of disease associations. RELEVANCE: Determination of anti-nuclear envelope antibody pattern by indirect immunofluorescence, with subsequent determination of the specific antibody, carries important diagnostic and prognostic implications in various autoimmune conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303304     DOI: 10.1053/sarh.2001.20266

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  12 in total

1.  Nucleoporin p62 antibodies in a case of mixed connective tissue disease.

Authors:  Doris M Kraemer; Michael R Kraus; Christian Kneitz; Hans-Peter Tony
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

Review 3.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 4.  The roles of the nuclear pore complex in cellular dysfunction, aging and disease.

Authors:  Stephen Sakuma; Maximiliano A D'Angelo
Journal:  Semin Cell Dev Biol       Date:  2017-05-12       Impact factor: 7.727

5.  Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients.

Authors:  A Skowera; E Stewart; E T Davis; A J Cleare; C Unwin; L Hull; K Ismail; G Hossain; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 6.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence.

Authors:  Y Ou; P Enarson; J B Rattner; S G Barr; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 8.  Autoantigens of the nuclear pore complex.

Authors:  P Enarson; J B Rattner; Y Ou; K Miyachi; T Horigome; M J Fritzler
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

9.  Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology.

Authors:  Qifeng Song; Guozhen Liu; Shaohui Hu; Yan Zhang; Yong Tao; Yuning Han; Haipan Zeng; Wei Huang; Fang Li; Peng Chen; Jianhui Zhu; Chaojun Hu; Shulan Zhang; Yongzhe Li; Heng Zhu; Lin Wu
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

Review 10.  Autoantibodies and their Judicious Use in Pediatric Rheumatology Practice.

Authors:  Biman Saikia; Amit Rawat; Pandiarajan Vignesh
Journal:  Indian J Pediatr       Date:  2015-12-03       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.